Skip to main content

Table 1 Patient characteristics at randomization

From: Magnesium sulfate for 6 vs 24 hours post delivery in patients who received magnesium sulfate for less than 8 hours before birth: a randomized clinical trial

  24 h Magnesium Sulphate 6 h Magnesium Sulphate p value
Post Delivery Group Post Delivery Group
N = 143 N = 141
Hypertensive disorder N (%)
 Severe Preeclampsia 115 (80.5) 116 (82.3) 0.68
 Superimposed preeclampsiaa 28 (19.5) 25 (17.7)  
Age - SD (year) 28.3 ± 7.5 28.7 ± 6.8 0.65
Parity 2.2 (1.6) 2.5 (1.7) 0.23
Mean Gestational Age (weeks) 36.2 (2.8) 36.1 (3.1) 0.73
Symptomsb n (%) 88 (61.5) 86 (61) 0.92
SBP mmHg, Mean (SD) 155.2 ± 13.1 158.0 ± 17.1 0.24
DBP mmHg, Mean (SD) 100.0 ± 8.9 102.3 ± 10.8 0.14
Hours with magnesium sulfate after loading dose to birth h (SD) 4.6 (2.3) 3.9 (3.8) 0.32
Cesarean Section, N (%) 92 (64.3) 96 (68.0) 0.50
  1. aChronic blood pressure with severe features of superimposed preeclampsia
  2. bOne or more symptoms: Severe headache, visual disturbances, epigastric pain